9 April 2024
Inspiration Healthcare Group plc
("Inspiration Healthcare" or the "Company")
Grant of Options under Sharesave Scheme
Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, announces that it has granted a total of 318,730 options over ordinary shares of 10 pence each in the capital of the Company ("Options") on 28 March 2024, under the Company's Sharesave Scheme (the "Scheme"), including a total of 5,225 Options to one Person Discharging Managerial Responsibilities ("PDMRs") as detailed below.
The Scheme is available to all employees subject to qualifying conditions. The Scheme was introduced to encourage wider employee share ownership of the Company. The Options are exercisable after three years at an exercise price of 28.4 pence, being a 20 per cent. discount to the closing price on 5 March 2024.
For further information:
| Inspiration Healthcare Group plc | Tel: +44 (0)330 175 0000 |
| Neil Campbell, Chief Executive Officer Alan Olby, Chief Financial Officer | |
| | |
| Liberum (Nominated Adviser & Broker) | Tel: +44 (0)20 3100 2000 |
| Phil Walker Richard Lindley | |
|
| |
| Walbrook PR Ltd (Media and Investor Relations) | Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
| Anna Dunphy | Mob: +44 (0) 7876 741 001 |
| Stephanie Cuthbert | Mob: +44 (0) 7796 794 663 |
| Louis Ashe-Jepson | Mob: +44 (0) 7747 515 393 |
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Annabelle Ball
| ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR
| ||||
| b) | Initial notification /Amendment | Initial | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Inspiration Healthcare Group plc
| ||||
| b) | LEI | 213800GKFT3ENAPMDL15
| ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a)
| Description of the financial instrument, type of instrument Identification code | Options over Ordinary Shares of 10p each in the capital of the Company ISIN: GB00BXDZL105 | ||||
| b) | Nature of the transaction | Grant of Options under the Company's Sharesave Scheme | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information - Aggregated volume - Price |
| ||||
| e) | Date of the transaction | 28 March 2024 | ||||
| f) | Place of the transaction | Outside of a trading venue | ||||
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and from its facility in Hailsham, East Sussex, and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.